SCOUT-HCM data show LVOT gradient reductions persisted, patients switching from placebo responded similarly, and no patient had LVEF below 50%.

On NET Cancer Day, a return visit for an over-the-counter antidiarrheal illustrates how pharmacists can identify a symptom pattern and help patients seek evaluation.

Survodutide met noninferiority for 5-point MACE, supporting its safety in adults with obesity and established CV disease or elevated risk.

A community oncology pharmacist explains how seeing patients across the course of their diagnosis builds trust and why accessibility remains the field’s biggest challenge despite advances in AI.

Kristen Hartzell, PharmD, explains that advance data collection, pre-filled consent forms, and peer and vendor support can help long-term care pharmacies run more efficient flu vaccine clinics for older adults.

Adding the IL-15 agonist to frontline BCG improved responses in carcinoma in situ without new safety signals; full data are expected at an upcoming congress.